Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.23 USD
Change Today -0.02 / -0.62%
Volume 7.4M
SNSS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel N. Swisher Jr.

Chief Executive Officer, President and Director, Sunesis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 28 board members in 3 different organizations across 4 different industries.

See Board Relationships
52$2,429,720
As of Fiscal Year 2014

Background*

Mr. Daniel N. Swisher, Jr., also known as Dan, has been the Chief Executive Officer of Sunesis Pharmaceuticals Inc., since January 2004 and has been its President since August 2005. Mr. Swisher has more than 25 years of experience in pharmaceutical product development, commercialization and finance. He joined Sunesis Pharmaceuticals in January 2002 and served as its Chief Business Officer & Chief Financial Officer from December 2001 to December 2003. He served as Chief ...

Read Full Background

Corporate Headquarters*

395 Oyster Point Boulevard
South San Francisco, California 94080

United States

Phone: 650-266-3500
Fax: 650-266-3501

Board Members Memberships*

2004-Present
Chief Executive Officer, President and Director
2011-Present
Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2015-Present
Director and Member of Audit Committee

Education*

BA
Yale University
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$488,094
Total Annual Compensation$488,094

Stock Options*

All Other Compensation$3,466
Exercisable Options1,325,403
Unexercisable Options905,209
Total Number of Options2,230,612

Total Compensation*

Total Annual Cash Compensation$693,560
Total Short Term Compensation$488,094
Other Long Term Compensation$3,466
Total Calculated Compensation$2,429,720
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNSS:US $3.23 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Adrian Adams Chief Executive Officer and Director
POZEN Inc.
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.